The distribution of Tumor Mutation Burden (TMB) was also similar in cancers with ZNF703 amplifications compared with ZNF703 non-amplified cancers, besides the subset with TMB above 13 where non-amplified tumors were more commonly observed, in the METABRIC cohort (Figure 4). The gene discussed is ZNF703; the disease is neoplasm.